Literature DB >> 28551623

The Immunological Roles of Periostin/Tumor-Associated Macrophage Axis in Development of Dermatofibrosarcoma Protuberans.

Taku Fujimura1, Aya Kakizaki2, Yota Sato2, Kayo Tanita2, Sadanori Furudate2, Setsuya Aiba2.   

Abstract

BACKGROUND/AIM: Dermatofibrosarcoma protuberance (DFSP) is a fibrohistiocytic tumor of intermediate malignancy characterized by slow infiltrative growth and a high tendency to recur locally. Periostin is involved in modulating cell function and inducing the production of proinflammatory cytokines, chemokines, and matrix metalloproteinases (MMPs) from tumor-associated macrophages (TAMs) to promote fibrosis and tumor growth. This study aimed to examine the cancer stroma of DFSP, focusing on TAMs-related proteins and MMPs. PATIENTS AND METHODS: Using immunohistochemical staining and DNA microarray database, we evaluated periostin, CD163, CD206, MMP1 and MMP12 in 10 cases of DFSP and dermatofibroma.
RESULTS: Dense deposits of periostin as well as a substantial number of CD163+ TAMs were detected at the peripheral areas of DFSP. Moreover, MMP1 and MMP12, that were selected by using a DNA microarray database of monocyte-derived macrophages, were observed in the TAMs-detected area.
CONCLUSION: Increased levels of MMP1 and MMP12 on TAMs in the peripheral areas of DFSP might contribute to local invasion. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  DFSP; MMP1; MMP12; periostin; tumor-associated macrophages

Mesh:

Substances:

Year:  2017        PMID: 28551623     DOI: 10.21873/anticanres.11639

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

Review 1.  Nanotechnology and Matrix Metalloproteinases in Cancer Diagnosis and Treatment.

Authors:  Georgina Gonzalez-Avila; Bettina Sommer; A Armando García-Hernandez; Carlos Ramos; Edgar Flores-Soto
Journal:  Front Mol Biosci       Date:  2022-06-01

2.  Low periostin expression predicts poor survival in intestinal type gastric cancer patients.

Authors:  Teming Zhang; Zheng Han; Arvine Chandoo; Xincheng Huang; Xiangwei Sun; Lele Ye; Changyuan Hu; Xiangyang Xue; Yingpeng Huang; Xian Shen; Wenjun Chang; Xiaoming Lin
Journal:  Cancer Manag Res       Date:  2018-12-18       Impact factor: 3.989

3.  Matrix Metalloproteinase 28-Bearing Microcystic Adnexal Carcinoma on the Back.

Authors:  Hiromu Chiba; Yumi Kambayashi; Erika Tamabuchi; Akira Hashimoto; Taku Fujimura
Journal:  Case Rep Oncol       Date:  2021-12-13

4.  Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis.

Authors:  Yao Song; Meiling Lu; Lijin Feng; Qian Chen; Hua Huang; Qing Lin
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

Review 5.  Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers.

Authors:  Taku Fujimura
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

Review 6.  Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Authors:  Taku Fujimura; Yumi Kambayashi; Yasuhiro Fujisawa; Takanori Hidaka; Setsuya Aiba
Journal:  Front Oncol       Date:  2018-01-23       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.